CA 19.9 ( PANCREATIC CANCER MONITOR) (IM035)

Description

The CA 19-9 (Cancer Antigen 19-9) test measures the level of CA 19-9, a tumor-associated antigen found in the blood. It is primarily used to monitor treatment response, evaluate disease progression, and detect recurrence in patients with pancreatic cancer. CA 19-9 may also be elevated in cancers of the bile ducts, gallbladder, stomach, and colon, as well as in certain benign conditions. Therefore, this test is not recommended as a screening or standalone diagnostic test for pancreatic cancer.

Report Time

Fasting

Not Required

Reporting Time

2-4 days

Gender

Male/Female

Age Group

5-99 yrs.

Pre-Test Instructions:

Fasting not required.
Inform the clinician about recent surgery, pancreatitis, or liver disease, as these may influence CA 19-9 levels.
Primarily used for monitoring disease progression, treatment response, and recurrence in gastrointestinal and pancreatic cancers.

Parameters Covered

रु 1,900

✔ Home collection available ✔ No hidden charges

Need help? Call 1800-123-4567

CA 19.9 ( PANCREATIC CANCER MONITOR) (IM035)

Description

Report Time

Pre-Test Instructions:

Parameters Covered

Find Tests By Categories